Aptorum Group Ltd (APM)
3.90
-0.93
(-19.25%)
USD |
NASDAQ |
May 21, 14:36
Aptorum Group Total Assets (Quarterly): 20.64M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.64M |
| June 30, 2023 | 14.41M |
| June 30, 2023 | 14.41M |
| December 31, 2022 | 20.87M |
| June 30, 2022 | 24.02M |
| June 30, 2022 | 24.02M |
| December 31, 2021 | 21.91M |
| June 30, 2021 | 31.71M |
| June 30, 2021 | 31.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 44.23M |
| June 30, 2020 | 23.31M |
| June 30, 2020 | 23.31M |
| December 31, 2019 | 23.95M |
| June 30, 2019 | 24.74M |
| June 30, 2019 | 24.74M |
| December 31, 2018 | 45.07M |
| June 30, 2018 | 41.47M |
| June 30, 2018 | 41.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.41M
Minimum
Jun 2023
44.23M
Maximum
Dec 2020
24.53M
Average
23.95M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 9.171M |
| Renalytix PLC | 8.769M |
| Immuron Ltd | 13.55M |
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.257M |
| Shareholders Equity (Quarterly) | 24.85M |